Amylyx Pharmaceuticals, Inc. Common Stock (AMLX)
NASDAQ · Healthcare
Amylyx Pharmaceuticals, Inc. Common Stock Income Statement 2021–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | |
|---|---|---|---|---|---|
| Revenues | |||||
| Revenue | 0 | 87.4M | 380.8M | 22.2M | 285,000 |
| Gross Profit | 0 | 81.4M | 355.3M | 19.2M | — |
| Profitability | |||||
| Operating Income | -153.3M | -314.7M | 38.8M | -201.3M | -82.7M |
| EBITDA | — | — | — | — | — |
| Net Income | -144.7M | -301.7M | 49.3M | -198.4M | -87.9M |
| Per Share Data | |||||
| EPS (diluted) | — | — | — | — | — |
| Shares Outstanding (dil.) | 95M | 68M | 70M | 58M | 7M |
Amylyx Pharmaceuticals, Inc. Common Stock Income Statement — FAQ
Amylyx Pharmaceuticals, Inc. Common Stock (AMLX) income statement over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AMLX's income statement history?
The chart and table above show Amylyx Pharmaceuticals, Inc. Common Stock's income statement by year and by quarter, including the growth rate.